Cardiac Development, Structure and Function

Science News

2020 AHA/ACC Consensus Conference on Professionalism and Ethics
Prevention of Viridans Group Streptococcal Infective Endocarditis
Sex-Specific Control of Human Heart Maturation by the Progesterone Receptor
Extracellular Tuning of Mitochondrial Respiration Leads to Aortic Aneurysm
Replacement Myocardial Fibrosis in Patients with Mitral Valve Prolapse: Relation to Mitral Regurgitation, Ventricular Remodeling and Arrhythmia

Journals

Response by Lee et al to Letter Regarding Article, “Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)”
Letter by Singh et al Regarding Article, “Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)”
In Vivo Characterization of Endogenous Cardiovascular Extracellular Vesicles in Larval and Adult Zebrafish
Endothelial Spns2 and ApoM Regulation of Vascular Tone and Hypertension Via Sphingosine‐1‐Phosphate
Clinical Outcomes of Autologous Stem Cell–Patch Implantation for Patients With Heart Failure With Nonischemic Dilated Cardiomyopathy

Continuing Education

Doctor looking into a microscope

Meet with us for compelling content and renewed connections at AHA Scientific Sessions 2021. In-person Event in Boston, Massachusetts + Virtual Experience, Saturday, November 13-15.

Abstract presentations are a key component of AHA Scientific Sessions. Abstract presenters have the option to present in person in Boston or as a part of the virtual experience.

The incentive to disseminate the latest cardiovascular and stroke science to colleagues around the world has never been greater.

Clinicians and Scientists thrive on collaboration and sharing their study findings. Present your innovative research to a global audience at Scientific Sessions, the world's premier cardiovascular conference.

We know your work is vital to saving lives. Share it with fellow researchers, clinicians, and scientists.

Since 1999, the BCVS Council has advanced understanding of mechanisms of basic cardiovascular regulation to support insights into cardiovascular disease and facilitate new therapies. Emphasis is on integrating molecular/cellular and physiological approaches to address problems relating to genomics, cell signaling, myocardial biology, circulatory physiology, pathophysiology, and peripheral vascular disease.


The GPM Council seeks to advance discovery and translation of biological insights from genetics and omics technologies to improve cardiovascular and brain health through better risk prediction, treatment and prevention for patients. Our expertise spans genetics, genomics, genomic medicine, epigenetics, transcriptomics, metabolomics, proteomics, microbiome, bioinformatics, computational science, and population health.


2018 Guideline on the Management of Blood Cholesterol

Sidney C. Smith, MD, past president of the American Heart Association, and Neil J. Stone, MD discuss the new 2018 Guideline on the Management of Blood Cholesterol, which was published during Scientific Sessions 2018 in Chicago.

American Heart Association Professional Members

Enjoy instant benefits!

  • Free Online Access to AHA Scientific Journals
  • Affiliate with our 16 Scientific Councils
  • Discounts on Scientific Conference Registration and Online Courses